| Page 1719 | Kisaco Research
 

Dhanusha Nalawansha

Postdoctoral Associate
Yale University

Dhanusha Nalawansha

Postdoctoral Associate
Yale University

Dhanusha Nalawansha

Postdoctoral Associate
Yale University
 

Derek Bartlett

Senior Principal Scientist
Pfizer

Derek Bartlett

Senior Principal Scientist
Pfizer

Derek Bartlett

Senior Principal Scientist
Pfizer
 

David Rubinsztein

Professor
Cambridge Institute for Medical Research

David Rubinsztein

Professor
Cambridge Institute for Medical Research

David Rubinsztein

Professor
Cambridge Institute for Medical Research
 

Daniel Scott

Research Specialist
St. Jude Children's Research Hospital

Daniel Scott

Research Specialist
St. Jude Children's Research Hospital

Daniel Scott

Research Specialist
St. Jude Children's Research Hospital
 

Christopher Kirk

President and CSO
Kezar Life Sciences Inc

Christopher Kirk

President and CSO
Kezar Life Sciences Inc

Christopher Kirk

President and CSO
Kezar Life Sciences Inc
 

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute
 

Andrew Benowitz

Senior Director, Protein Degradation DPU Head
GSK

Andrew Benowitz

Senior Director, Protein Degradation DPU Head
GSK

Andrew Benowitz

Senior Director, Protein Degradation DPU Head
GSK
 

Carlotta Cecchini

PhD Candidate, Pharmaceutical Biochemistry/Chemistry
University of Geneva

Carlotta Cecchini received her Master’s degree in 2017 in Pharmaceutical Sciences at the University of Bologna Bologna (Italy), where she was awarded a scholarship for two consecutive years (2015/2016) for her excellent grades. In 2018, she joined the group of Prof. Leonardo Scapozza (Biochemistry/Chemistry group) at the University of Geneva to start a Ph.D. in medicinal chemistry. Her research topic mainly focuses on the design and synthesis PROTACs as oncogenic agents.

Carlotta Cecchini

PhD Candidate, Pharmaceutical Biochemistry/Chemistry
University of Geneva

Carlotta Cecchini

PhD Candidate, Pharmaceutical Biochemistry/Chemistry
University of Geneva

Carlotta Cecchini received her Master’s degree in 2017 in Pharmaceutical Sciences at the University of Bologna Bologna (Italy), where she was awarded a scholarship for two consecutive years (2015/2016) for her excellent grades. In 2018, she joined the group of Prof. Leonardo Scapozza (Biochemistry/Chemistry group) at the University of Geneva to start a Ph.D. in medicinal chemistry. Her research topic mainly focuses on the design and synthesis PROTACs as oncogenic agents. Through her thesis work, Carlotta gained experience in the field of Targeted Protein Degradation, and in particular, in PROTAC rational design. She plans to obtain her Ph.D. degree by the end of 2022.

 

Alexei Kisselev

Associate Professor
Auburn University

Alexei Kisselev

Associate Professor
Auburn University

Alexei Kisselev

Associate Professor
Auburn University
 

Chris Eliasmith

Co-CEO
Applied Brain Research

Chris is the co-inventor of the Neural Engineering Framework (NEF), the Neural Engineering Objects (Nengo) software environment, and the Semantic Pointer Architecture (SPA), all of which are dedicated to understanding how the brain works. His team has developed the Semantic Pointer Architecture Unified Network (Spaun) which is the most realistic functional brain simulation yet developed. He won the prestigious 2015 NSERC Polanyi Award for his research.

Chris Eliasmith

Co-CEO
Applied Brain Research

Chris Eliasmith

Co-CEO
Applied Brain Research

Chris is the co-inventor of the Neural Engineering Framework (NEF), the Neural Engineering Objects (Nengo) software environment, and the Semantic Pointer Architecture (SPA), all of which are dedicated to understanding how the brain works. His team has developed the Semantic Pointer Architecture Unified Network (Spaun) which is the most realistic functional brain simulation yet developed. He won the prestigious 2015 NSERC Polanyi Award for his research.

Chris is the Canada Research Chair in Theoretical Neuroscience. At the University of Waterloo, Chris is jointly appointed in the Philosophy and Systems Design Engineering departments, as well as being cross-appointed to the Computer Science department. Chris has supervised students in each of these departments as well as in Biology and Psychology. Chris is the director of the Centre for Theoretical Neuroscience (CTN) at the University of Waterloo. The Centre brings together researchers across many faculties as diverse as math, engineering, arts and science who are interested in computational and theoretical models of neural systems.

The Computational Neuroscience Research Group (CNRG) is Chris’ research lab which is associated with the CTN. The CNRG site contains the most up-to-date information on Chris’ team’s research. Chris has published two books: How to Build a Brain (Oxford University Press) and his seminal Neural Engineering.

When he is not pushing the boundaries of theoretical neuroscience forward or hanging out with his team at the CNRG, Chris spends time with his family and occasionally straps on the blades for a game of hockey near his home in Waterloo. He has a Bacon-Erdos number of 8.